These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 739712)

  • 21. Hanganutziu and Deicher type heterophile antigen expressed on the cell surface of Marek's disease lymphoma-derived cell lines.
    Ikuta K; Kitamoto N; Shoji H; Kato S; Naiki M
    Biken J; 1981 Jun; 24(1-2):23-37. PubMed ID: 7030304
    [No Abstract]   [Full Text] [Related]  

  • 22. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease.
    Powell PC; Rowell JG
    J Natl Cancer Inst; 1977 Sep; 59(3):919-24. PubMed ID: 197249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of immunity in coccidiosis in chickens experimentally infected with Marek's disease].
    Penev P; Nikolova M; Stefanova M
    Vet Med Nauki; 1975; 12(9):46-50. PubMed ID: 1210012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of a T cell-mediated immune response in Marek's disease virus-infected chickens by vaccination with a related virus.
    Schierman LW; Theis GA; McBride RA
    J Immunol; 1976 May; 116(5):1497-9. PubMed ID: 774984
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
    Schat KA; Murthy KK
    J Virol; 1980 Apr; 34(1):130-5. PubMed ID: 6966335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of a Marek's disease lymphoma in syngeneic chickens.
    Theis GA; Schierman LW; McBride RA
    J Immunol; 1974 Dec; 113(6):1710-5. PubMed ID: 4139194
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines.
    Powell PC
    Nature; 1975 Oct; 257(5528):684-5. PubMed ID: 810724
    [No Abstract]   [Full Text] [Related]  

  • 28. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines.
    Schat KA; Shek WR; Calnek BW; Abplanalp H
    Int J Cancer; 1982 Feb; 29(2):187-94. PubMed ID: 6277809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of monoclonal antibodies reactive with Marek's disease tumor-associated surface antigen (MATSA).
    Ikuta K; Ueda S; Kato S; Ono K; Osafune S; Yoshida I; Konobe T; Naito I; Naito M; Hirai K
    Biken J; 1984 Dec; 27(4):183-8. PubMed ID: 6399439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated immunity to tumor antigen in Marek's disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase.
    Sharma JM
    Infect Immun; 1977 Oct; 18(1):46-51. PubMed ID: 302827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of histocompatibility and immune response of chickens selected for resistance and susceptibility to Marek's disease.
    Keller LH; Sevoian M
    Avian Dis; 1983; 27(1):7-20. PubMed ID: 6847551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cell mediated immune response by nonspecific stimulator of immunity against antigenically unrelated oncogenic virus (Marek's disease virus).
    Kishore S; Mallick BB
    Indian J Exp Biol; 1989 Jun; 27(6):529-31. PubMed ID: 2479599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen.
    Lee LF; Liu X; Sharma JM; Nazerian K; Bacon LD
    J Immunol; 1983 Feb; 130(2):1007-11. PubMed ID: 6294177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of anti-tumoral cell-mediated cytotoxicity during the course of Marek's disease in chickens.
    Queré P; Dambrine G
    Ann Rech Vet; 1988; 19(3):193-201. PubMed ID: 3190140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a putative tumor-associated surface antigen on normal versus Marek's disease virus-transformed lymphocytes.
    McColl KA; Calnek BW; Harris WV; Schat KA; Lee LF
    J Natl Cancer Inst; 1987 Nov; 79(5):991-1000. PubMed ID: 3479647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to Marek's disease. Effect of Corynebacterium parvum and Marek's tumor cell vaccines on tumorigenesis in chickens.
    Donahoe J; Kleven S; Eidson C
    J Natl Cancer Inst; 1978 Apr; 60(4):829-33. PubMed ID: 24754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal characteristics of six cultured lymphoblastoid cell lines originating from Marek's disease lymphomas.
    Takagi N; Sasaki M; Ikuta K; Kato S
    Biken J; 1977 Mar; 20(1):21-8. PubMed ID: 69431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity and Marek's disease.
    Calnek BW
    Bibl Haematol; 1973; 39():389-94. PubMed ID: 4591437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.